Glymphatic-assisted perivascular brain delivery of intrathecal small gold nanoparticles

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 8,54 MB, PDF-dokument

Nanoparticles are ultrafine particulate matter having considerable potential for treatment of central nervous system (CNS) disorders. Despite their tiny size, the blood-brain barrier (BBB) restricts their access to the CNS. Their direct cerebrospinal fluid (CSF) administration bypasses the BBB endothelium, but still fails to give adequate brain uptake. We present a novel approach for efficient CNS delivery of 111In-radiolabelled gold nanoparticles (AuNPs; 10–15 nm) via intra-cisterna magna administration, with tracking by SPECT imaging. To accelerate CSF brain influx, we administered AuNPs intracisternally in conjunction with systemic hypertonic saline, which dramatically increased the parenchymal AuNP uptake, especially in deep brain regions. AuNPs entered the CNS along periarterial spaces as visualized by MRI of gadolinium-labelled AuNPs and were cleared from brain within 24 h and excreted through the kidneys. Thus, the glymphatic-assisted perivascular network augment by systemic hypertonic saline is a pathway for highly efficient brain-wide distribution of small AuNPs.
OriginalsprogEngelsk
TidsskriftJournal of Controlled Release
Vol/bind355
Sider (fra-til)135-148
Antal sider14
ISSN0168-3659
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
We thank Dan Xue and Austin Fisher for expert graphic illustrations. Mikael Palner is acknowledged for expert support with SPECT imaging. Prof. Paul Cumming of Bern University is acknowledged for scientific proofreading. This work was supported by Lundbeck Foundation (M.N.), Novo Nordisk Foundation (M.N.), Finnish Medical Foundation (T.O.L.), Paulo Foundation (T.O.L.), University of Helsinki Research Funds (T.O.L.), European Union‘s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement GlymPharma No 798944 (T.O.L.), and The Acta Anaesthesiologica Scandinavica Foundation (T.J.L.).

Publisher Copyright:
© 2023

ID: 371284641